Keith Crosby

Capsid Serotype and Timing of Injection Determines AAV Transduction in the Neonatal Mice Brain

Paramita Chakrabarty, Awilda M. Rosario, Pedro E. Cruz et al. · PLoS ONE · 2013 · 210 citations · Full text

In Vivo Gene Therapy, Capsid Serotype, Viral Pathogenesis +16

Widespread and Efficient Transduction of Spinal Cord and Brain Following Neonatal AAV Injection and Potential Disease Modifying Effect in ALS Mice

Jacob I. Ayers, Susan Fromholt, Olga Sinyavskaya et al. · Molecular Therapy · 2014 · 77 citations · Full text

Changes in proteome solubility indicate widespread proteostatic disruption in mouse models of neurodegenerative disease

Michael C. Pace, Guilian Xu, Susan Fromholt et al. · Acta Neuropathologica · 2018 · 32 citations · Full text

Neurodegenerative Diseases, Alzheimer's Disease, Biochemistry +12

Tissue-specific activation of gene expression by the Synergistic Activation Mediator (SAM) CRISPRa system in mice

Charleen Hunt, Suzanne A. Hartford, Derek W. R. White et al. · Nature Communications · 2021 · 24 citations · Full text

Analysis of Proteolytic Processes and Enzymatic Activities in the Generation of Huntingtin N-Terminal Fragments in an HEK293 Cell Model

Andrew T.N. Tebbenkamp, Keith Crosby, Zoe Siemienski et al. · PLoS ONE · 2012 · 19 citations · Full text